Annual Total Assets
$14.11 M
-$2.63 M-15.70%
31 December 2023
Summary:
GT Biopharma annual total assets is currently $14.11 million, with the most recent change of -$2.63 million (-15.70%) on 31 December 2023. During the last 3 years, it has risen by +$8.45 million (+149.23%). GTBP annual total assets is now -94.45% below its all-time high of $254.37 million, reached on 31 December 2017.GTBP Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$6.76 M
-$2.51 M-27.06%
30 September 2024
Summary:
GT Biopharma quarterly total assets is currently $6.76 million, with the most recent change of -$2.51 million (-27.06%) on 30 September 2024. Over the past year, it has dropped by -$9.39 million (-58.14%). GTBP quarterly total assets is now -97.37% below its all-time high of $257.33 million, reached on 31 March 2018.GTBP Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.7% | -58.1% |
| 3 y3 years | +149.2% | -81.1% |
| 5 y5 years | -44.5% | +1302.3% |
GTBP Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.1% | +149.2% | -81.1% | at low |
| 5 y | 5 years | -56.1% | +3462.9% | -82.9% | +2191.2% |
| alltime | all time | -94.5% | >+9999.0% | -97.4% | >+9999.0% |
GT Biopharma Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.76 M(-27.1%) |
| June 2024 | - | $9.27 M(-6.5%) |
| Mar 2024 | - | $9.91 M(-29.7%) |
| Dec 2023 | $14.11 M(-15.7%) | $14.11 M(-12.6%) |
| Sept 2023 | - | $16.15 M(-11.0%) |
| June 2023 | - | $18.14 M(-9.7%) |
| Mar 2023 | - | $20.09 M(+20.0%) |
| Dec 2022 | $16.74 M(-48.0%) | $16.74 M(-20.6%) |
| Sept 2022 | - | $21.07 M(-12.8%) |
| June 2022 | - | $24.17 M(-11.9%) |
| Mar 2022 | - | $27.44 M(-14.7%) |
| Dec 2021 | $32.17 M(+468.3%) | $32.17 M(-10.1%) |
| Sept 2021 | - | $35.80 M(-9.5%) |
| June 2021 | - | $39.57 M(+43.1%) |
| Mar 2021 | - | $27.64 M(+388.3%) |
| Dec 2020 | $5.66 M(+1329.5%) | $5.66 M(+517.3%) |
| Sept 2020 | - | $917.00 K(-13.7%) |
| June 2020 | - | $1.06 M(+260.3%) |
| Mar 2020 | - | $295.00 K(-25.5%) |
| Dec 2019 | $396.00 K(-98.4%) | $396.00 K(-17.8%) |
| Sept 2019 | - | $482.00 K(-98.1%) |
| June 2019 | - | $25.71 M(+0.7%) |
| Mar 2019 | - | $25.54 M(+0.6%) |
| Dec 2018 | $25.40 M(-90.0%) | $25.40 M(-4.3%) |
| Sept 2018 | - | $26.54 M(-89.6%) |
| June 2018 | - | $255.01 M(-0.9%) |
| Mar 2018 | - | $257.33 M(+1.2%) |
| Dec 2017 | $254.37 M(>+9900.0%) | $254.37 M(-0.8%) |
| Sept 2017 | - | $256.52 M(>+9900.0%) |
| June 2017 | - | $42.00 K(-82.4%) |
| Mar 2017 | - | $238.00 K(+852.0%) |
| Dec 2016 | $25.00 K(-53.7%) | $25.00 K(-84.4%) |
| Sept 2016 | - | $160.00 K(-55.8%) |
| June 2016 | - | $362.00 K(+878.4%) |
| Mar 2016 | - | $37.00 K(-31.5%) |
| Dec 2015 | $54.00 K(-93.9%) | $54.00 K(+10.2%) |
| Sept 2015 | - | $49.00 K(-62.9%) |
| June 2015 | - | $132.00 K(-90.7%) |
| Mar 2015 | - | $1.43 M(+60.5%) |
| Dec 2014 | $888.00 K(+504.1%) | $888.00 K(+25.1%) |
| Sept 2014 | - | $710.00 K(+1265.4%) |
| June 2014 | - | $52.00 K(-49.5%) |
| Mar 2014 | - | $103.00 K(-29.9%) |
| Dec 2013 | $147.00 K(-35.0%) | $147.00 K(+137.1%) |
| Sept 2013 | - | $62.00 K(-59.7%) |
| June 2013 | - | $154.00 K(+30.5%) |
| Mar 2013 | - | $118.00 K(-47.8%) |
| Dec 2012 | $226.00 K(+75.2%) | $226.00 K(+156.8%) |
| Sept 2012 | - | $88.00 K(-29.6%) |
| June 2012 | - | $125.00 K(-24.7%) |
| Mar 2012 | - | $166.00 K(+28.7%) |
| Dec 2011 | $129.00 K(-30.3%) | $129.00 K(-65.2%) |
| Sept 2011 | - | $371.00 K(+62.7%) |
| June 2011 | - | $228.00 K(+66.4%) |
| Mar 2011 | - | $137.00 K(-25.9%) |
| Dec 2010 | $185.00 K(-86.6%) | $185.00 K(-43.8%) |
| Sept 2010 | - | $329.00 K(-52.1%) |
| June 2010 | - | $687.00 K(-25.6%) |
| Mar 2010 | - | $924.00 K(-33.2%) |
| Dec 2009 | $1.38 M(+134.6%) | $1.38 M(+135.0%) |
| Sept 2009 | - | $589.00 K(-8.3%) |
| June 2009 | - | $642.00 K(+15.1%) |
| Mar 2009 | - | $558.00 K(-5.4%) |
| Dec 2008 | $590.00 K(-87.9%) | $590.00 K(-29.8%) |
| Sept 2008 | - | $841.00 K(-39.4%) |
| June 2008 | - | $1.39 M(-70.9%) |
| Mar 2008 | - | $4.76 M(-2.0%) |
| Dec 2007 | $4.86 M(-39.3%) | $4.86 M(-12.3%) |
| Sept 2007 | - | $5.54 M(+6.1%) |
| June 2007 | - | $5.22 M(+6.8%) |
| Mar 2007 | - | $4.88 M(-38.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $8.00 M(+2.4%) | $8.00 M(+4.8%) |
| Sept 2006 | - | $7.63 M(+0.6%) |
| June 2006 | - | $7.58 M(-4.4%) |
| Mar 2006 | - | $7.93 M(+1.5%) |
| Dec 2005 | $7.81 M(-7.9%) | $7.81 M(+36.9%) |
| Sept 2005 | - | $5.70 M(-8.1%) |
| June 2005 | - | $6.20 M(-7.3%) |
| Mar 2005 | - | $6.70 M(-21.0%) |
| Dec 2004 | $8.48 M(+331.8%) | $8.48 M(+218.4%) |
| Sept 2004 | - | $2.66 M(-3.5%) |
| June 2004 | - | $2.76 M(+40.1%) |
| Mar 2004 | - | $1.97 M(+0.3%) |
| Dec 2003 | $1.96 M(-1.1%) | $1.96 M(+1.3%) |
| Sept 2003 | - | $1.94 M(+2.7%) |
| June 2003 | - | $1.89 M(-1.8%) |
| Mar 2003 | - | $1.92 M(-3.2%) |
| Dec 2002 | $1.99 M(+15.3%) | $1.99 M(-4.9%) |
| Sept 2002 | - | $2.09 M(-19.4%) |
| June 2002 | - | $2.59 M(-10.7%) |
| Mar 2002 | - | $2.90 M(+68.4%) |
| Dec 2001 | $1.72 M(-69.4%) | $1.72 M(-8.8%) |
| Sept 2001 | - | $1.89 M(-27.8%) |
| June 2001 | - | $2.61 M(-39.1%) |
| Mar 2001 | - | $4.29 M(-23.6%) |
| Dec 2000 | $5.63 M(+8.5%) | $5.63 M(-20.9%) |
| Sept 2000 | - | $7.11 M(-14.8%) |
| June 2000 | - | $8.34 M(+2.2%) |
| Mar 2000 | - | $8.16 M(+57.4%) |
| Dec 1999 | $5.18 M(-53.7%) | $5.18 M(-0.3%) |
| Sept 1999 | - | $5.20 M(-17.5%) |
| June 1999 | - | $6.30 M(-23.2%) |
| Mar 1999 | - | $8.20 M(-26.8%) |
| Dec 1998 | $11.20 M(-11.1%) | $11.20 M(-16.4%) |
| Sept 1998 | - | $13.40 M(+1.5%) |
| June 1998 | - | $13.20 M(+25.7%) |
| Mar 1998 | - | $10.50 M(-16.7%) |
| Dec 1997 | $12.60 M(+57.5%) | $12.60 M(+32.6%) |
| Sept 1997 | - | $9.50 M(-9.5%) |
| June 1997 | - | $10.50 M(+40.0%) |
| Mar 1997 | - | $7.50 M(-6.3%) |
| Dec 1996 | $8.00 M(-19.2%) | $8.00 M(0.0%) |
| Sept 1996 | - | $8.00 M(-10.1%) |
| June 1996 | - | $8.90 M(-6.3%) |
| Mar 1996 | - | $9.50 M(-4.0%) |
| Dec 1995 | $9.90 M(-11.6%) | $9.90 M(-3.9%) |
| Sept 1995 | - | $10.30 M(-2.8%) |
| June 1995 | - | $10.60 M(-4.5%) |
| Mar 1995 | - | $11.10 M(-0.9%) |
| Dec 1994 | $11.20 M(+261.3%) | $11.20 M(-7.4%) |
| Sept 1994 | - | $12.10 M(+227.0%) |
| June 1994 | - | $3.70 M(+19.4%) |
| Mar 1994 | - | $3.10 M(0.0%) |
| Dec 1993 | $3.10 M(-36.7%) | $3.10 M(-11.4%) |
| Sept 1993 | - | $3.50 M(0.0%) |
| June 1993 | - | $3.50 M(-28.6%) |
| Mar 1993 | - | $4.90 M(0.0%) |
| Dec 1992 | $4.90 M(+2.1%) | $4.90 M(+2.1%) |
| Sept 1992 | - | $4.80 M(0.0%) |
| June 1992 | - | $4.80 M(+6.7%) |
| Mar 1992 | - | $4.50 M(-6.3%) |
| Dec 1991 | $4.80 M(-4.0%) | $4.80 M(-9.4%) |
| Sept 1991 | - | $5.30 M(+6.0%) |
| Dec 1990 | $5.00 M(+13.6%) | $5.00 M(+13.6%) |
| Dec 1989 | $4.40 M(+25.7%) | $4.40 M(+25.7%) |
| Dec 1988 | $3.50 M(+6.1%) | $3.50 M(+6.1%) |
| Dec 1987 | $3.30 M(0.0%) | $3.30 M(0.0%) |
| Dec 1986 | $3.30 M(+3.1%) | $3.30 M(+3.1%) |
| Dec 1985 | $3.20 M(-15.8%) | $3.20 M(-15.8%) |
| Dec 1984 | $3.80 M(-9.5%) | - |
| Dec 1984 | - | $3.80 M |
| Feb 1984 | $4.20 M | - |
FAQ
- What is GT Biopharma annual total assets?
- What is the all time high annual total assets for GT Biopharma?
- What is GT Biopharma annual total assets year-on-year change?
- What is GT Biopharma quarterly total assets?
- What is the all time high quarterly total assets for GT Biopharma?
- What is GT Biopharma quarterly total assets year-on-year change?
What is GT Biopharma annual total assets?
The current annual total assets of GTBP is $14.11 M
What is the all time high annual total assets for GT Biopharma?
GT Biopharma all-time high annual total assets is $254.37 M
What is GT Biopharma annual total assets year-on-year change?
Over the past year, GTBP annual total assets has changed by -$2.63 M (-15.70%)
What is GT Biopharma quarterly total assets?
The current quarterly total assets of GTBP is $6.76 M
What is the all time high quarterly total assets for GT Biopharma?
GT Biopharma all-time high quarterly total assets is $257.33 M
What is GT Biopharma quarterly total assets year-on-year change?
Over the past year, GTBP quarterly total assets has changed by -$9.39 M (-58.14%)